Roche announced the appointment of Dan Malarek as President and CEO of Roche Diagnostics North America, effective August 1, 2026. Malarek currently serves as Chief Executive Officer of Foundation Medicine Inc., an independent affiliate of the Roche Group. Malarek succeeds Brad Moore, who will retire at the end of July…
LumaCina, a global supplier and marketer of sterile injectable pharmaceutical products and a Bridgewest Group portfolio company, announced the appointment of Gary Bird as Chief Executive Officer. Bird was appointed by Executive Chair Mark Crotty, who will continue to lead LumaCina's long-term strategy, overseeing the…
Cellular Intelligence, the AI company building a universal foundation model of cell signaling, announced the addition of two senior leaders to its executive team, as it prepares for the next phase of growth. Jonathan Alspaugh, chief strategy officer, joins with over 15 years of experience in biopharma strategy, financ…
DePuy Synthes, a global leader in orthopaedic technologies and solutions, announced the appointment of Christina Zamarro as Chief Financial Officer, DePuy Synthes, effective July 13, 2026. Zamarro brings over 25 years of financial leadership experience serving in multitude of roles across treasury, investor relations…
Syngene International, a global contract research, development, and manufacturing organization (CRDMO), announced that Siddharth Mittal has assumed the role of Managing Director and Chief Executive Officer of the Company, effective 1 July 2026.Siddharth succeeds Peter Bains, who completed his tenure as Managing Direct…
Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced the appointment of Torsten Woehr as Chief Executive Officer (CEO), effective August 1, 2026. Torsten Woehr, incoming CEO of Rentschler Biopharma, commented: “Rentschler Biopharma is r…
Muna Therapeutics, a biotechnology company pioneering novel therapeutics for neurodegenerative diseases, announced a CEO transition. Rita Balice-Gordon, Ph.D., Muna's founding CSO and CEO since 2021, will step down and join the Company's Board of Directors. Michel Detheux, Ph.D., a seasoned biotech entrepreneur and fo…
Sanofi announced the appointment of Paulo Fontoura, MD, PhD, FAAN, as Executive Vice President, Global Head of Research & Development Pharma, effective September 1, 2026. He will be a member of Sanofi's Executive Committee, based in Paris, and will report to Chief Executive Officer Belén Garijo. As head of R&D…
Pfizer Inc. announced that Dave Denton, Chief Financial Officer, will step down from his current role and leave the company on August 15 for a professional opportunity outside of the pharmaceutical industry in consumer goods, which he has accepted. The company has named Cecile Guegan, currently Senior Vice President,…
Bristol Myers Squibb (BMS), a leading global biopharmaceutical company, has appointed Mayada Al-Ahmad to the position of General Manager of Saudi Arabia and Gulf Countries effective June 1, 2026. In this role, Mayada will lead the affiliate spanning Saudi Arabia, the United Arab Emirates, Kuwait, Qatar, Oman, Bahrain,…
Page 4 of 16